A phase II study of maintenance rucaparib in patients with platinum sensitive, advanced pancreatic cancer and a pathogenic germline or somatic variant in BRCA1, BRCA2 or PALB2 : A four year survival update.

Autor: Reiss, Kim Anna, O'Hara, Mark H., Teitelbaum, Ursina R., Karasic, Thomas Benjamin, Schneider, Charles John, Pratz, Caroline F., Nathanson, Katherine L., Vonderheide, Robert H., Domchek, Susan M.
Zdroj: Journal of Clinical Oncology; 2024 Supplement 3, Vol. 42, p661-661, 117p
Databáze: Supplemental Index